Avances en Medicina
Estudio IMPROVE-IT. Buenas noticias para ezetimiba y para los pacientes
IMPROVE-IT trial. Good news for ezetimibe and for patients
Leído
20897
Vecesse ha leído el artículo
2868
Total PDF
18029
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 47 | 9 | 56 |
| 2025 11 | 250 | 49 | 299 |
| 2025 10 | 222 | 30 | 252 |
| 2025 9 | 206 | 43 | 249 |
| 2025 8 | 180 | 35 | 215 |
| 2025 7 | 184 | 19 | 203 |
| 2025 6 | 249 | 22 | 271 |
| 2025 5 | 211 | 24 | 235 |
| 2025 4 | 260 | 30 | 290 |
| 2025 3 | 258 | 57 | 315 |
| 2025 2 | 246 | 23 | 269 |
| 2025 1 | 172 | 25 | 197 |
| 2024 12 | 212 | 19 | 231 |
| 2024 11 | 277 | 25 | 302 |
| 2024 10 | 248 | 48 | 296 |
| 2024 9 | 194 | 23 | 217 |
| 2024 8 | 203 | 22 | 225 |
| 2024 7 | 252 | 24 | 276 |
| 2024 6 | 256 | 39 | 295 |
| 2024 5 | 248 | 22 | 270 |
| 2024 4 | 210 | 21 | 231 |
| 2024 3 | 204 | 11 | 215 |
| 2024 2 | 251 | 21 | 272 |
| 2024 1 | 283 | 20 | 303 |
| 2023 12 | 215 | 21 | 236 |
| 2023 11 | 288 | 33 | 321 |
| 2023 10 | 316 | 28 | 344 |
| 2023 9 | 151 | 17 | 168 |
| 2023 8 | 165 | 16 | 181 |
| 2023 7 | 192 | 14 | 206 |
| 2023 6 | 220 | 14 | 234 |
| 2023 5 | 180 | 11 | 191 |
| 2023 4 | 138 | 24 | 162 |
| 2023 3 | 167 | 9 | 176 |
| 2023 2 | 159 | 20 | 179 |
| 2022 1 | 116 | 6 | 122 |
| 2022 12 | 86 | 14 | 100 |
| 2022 11 | 178 | 27 | 205 |
| 2022 10 | 159 | 29 | 188 |
| 2022 9 | 158 | 31 | 189 |
| 2022 8 | 150 | 24 | 174 |
| 2022 7 | 94 | 18 | 112 |
| 2022 6 | 95 | 28 | 123 |
| 2022 5 | 114 | 21 | 135 |
| 2022 4 | 93 | 16 | 109 |
| 2022 3 | 178 | 27 | 205 |
| 2022 2 | 133 | 16 | 149 |
| 2021 1 | 96 | 19 | 115 |
| 2021 12 | 73 | 16 | 89 |
| 2021 11 | 101 | 25 | 126 |
| 2021 10 | 110 | 43 | 153 |
| 2021 9 | 116 | 22 | 138 |
| 2021 8 | 102 | 25 | 127 |
| 2021 7 | 106 | 28 | 134 |
| 2021 6 | 108 | 22 | 130 |
| 2021 5 | 102 | 26 | 128 |
| 2021 4 | 203 | 33 | 236 |
| 2021 3 | 142 | 45 | 187 |
| 2021 2 | 130 | 69 | 199 |
| 2020 1 | 106 | 26 | 132 |
| 2020 12 | 90 | 11 | 101 |
| 2020 11 | 146 | 22 | 168 |
| 2020 10 | 61 | 27 | 88 |
| 2020 9 | 129 | 25 | 154 |
| 2020 8 | 138 | 18 | 156 |
| 2020 7 | 120 | 20 | 140 |
| 2020 6 | 91 | 14 | 105 |
| 2020 5 | 107 | 31 | 138 |
| 2020 4 | 111 | 29 | 140 |
| 2020 3 | 99 | 20 | 119 |
| 2020 2 | 119 | 27 | 146 |
| 2020 1 | 101 | 13 | 114 |
| 2019 12 | 87 | 8 | 95 |
| 2019 11 | 130 | 30 | 160 |
| 2019 10 | 203 | 37 | 240 |
| 2019 9 | 294 | 29 | 323 |
| 2019 8 | 232 | 18 | 250 |
| 2019 7 | 138 | 23 | 161 |
| 2019 6 | 133 | 39 | 172 |
| 2019 5 | 304 | 67 | 371 |
| 2019 4 | 150 | 43 | 193 |
| 2019 3 | 57 | 26 | 83 |
| 2019 2 | 74 | 30 | 104 |
| 2019 1 | 60 | 21 | 81 |
| 2018 12 | 47 | 18 | 65 |
| 2018 11 | 51 | 32 | 83 |
| 2018 10 | 97 | 11 | 108 |
| 2018 9 | 66 | 25 | 91 |
| 2018 8 | 35 | 19 | 54 |
| 2018 7 | 40 | 10 | 50 |
| 2018 6 | 58 | 7 | 65 |
| 2018 5 | 50 | 4 | 54 |
| 2018 4 | 58 | 11 | 69 |
| 2018 3 | 40 | 5 | 45 |
| 2018 2 | 55 | 2 | 57 |
| 2018 1 | 15 | 3 | 18 |
| 2017 12 | 33 | 1 | 34 |
| 2017 11 | 66 | 8 | 74 |
| 2017 10 | 53 | 7 | 60 |
| 2017 9 | 51 | 2 | 53 |
| 2017 8 | 96 | 0 | 96 |
| 2017 7 | 63 | 7 | 70 |
| 2017 6 | 78 | 3 | 81 |
| 2017 5 | 88 | 7 | 95 |
| 2017 4 | 65 | 2 | 67 |
| 2017 3 | 128 | 19 | 147 |
| 2017 2 | 335 | 13 | 348 |
| 2016 1 | 107 | 4 | 111 |
| 2016 12 | 102 | 12 | 114 |
| 2016 11 | 156 | 16 | 172 |
| 2016 10 | 169 | 16 | 185 |
| 2016 9 | 189 | 23 | 212 |
| 2016 8 | 136 | 25 | 161 |
| 2016 7 | 119 | 28 | 147 |
| 2016 6 | 147 | 30 | 177 |
| 2016 5 | 138 | 28 | 166 |
| 2016 4 | 137 | 29 | 166 |
| 2016 3 | 141 | 21 | 162 |
| 2016 2 | 107 | 21 | 128 |
| 2015 1 | 124 | 28 | 152 |
| 2015 12 | 90 | 23 | 113 |
| 2015 11 | 180 | 34 | 214 |
| 2015 10 | 167 | 37 | 204 |
| 2015 9 | 113 | 36 | 149 |
| 2015 8 | 91 | 29 | 120 |
| 2015 7 | 211 | 60 | 271 |
Mostrar todo
